The first stop for professional medicines advice

Rizatriptan

Published
Topics: Anaesthesia and painCCG commissioned new medicinesNeurological disorders · New MedicinesPatent expiriesRizatriptanSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Medicine Compliance Aid Stability
    1. Maxalt · Organon Pharma (UK) Limited
    2. Maxalt Melt · Organon Pharma (UK) Limited
  3. Lactation Safety Information

dm+d

108411001

Medicine Compliance Aid Stability

MaxaltOrganon Pharma (UK) Limited

Organon Pharma (UK) Limited
Maxalt
Tablets 5mg, 10mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage.
22 November 2022
Usage of Medicines in Compliance Aids

Maxalt MeltOrganon Pharma (UK) Limited

Organon Pharma (UK) Limited
Maxalt Melt
Oral lyophilisates 10mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Unsuitable for MCA as hygroscopic.
22 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Caution
Sumatriptan
No published evidence of safety
5HT1-receptor agonist for treatment of acute migraine
Safety in Lactation: Antimigraine drugs
18 September 2020
Bibliography